{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:15:05Z","timestamp":1788246905833,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Science and Technology Project of Henan Province","award":["LHGJ20220850"],"award-info":[{"award-number":["LHGJ20220850"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86439-4","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:22:45Z","timestamp":1737458565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Target-specific peptides for BK virus agnoprotein identified through phage display screening: advancing antiviral therapeutics"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaofei","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CuiXia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"7712","key":"86439_CR1","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","volume":"297","author":"SD Gardner","year":"1971","unstructured":"Gardner, S. D., Field, A. M., Coleman, D. V. & Hulme, B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 297 (7712), 1253\u20131257 (1971).","journal-title":"Lancet"},{"issue":"6","key":"86439_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1099\/jgv.0.000839","volume":"98","author":"U Moens","year":"2017","unstructured":"Moens, U. et al. ICTV Virus Taxonomy Profile: Polyomaviridae. J. Gen. Virol. 98 (6), 1159\u20131160 (2017).","journal-title":"J. Gen. Virol."},{"issue":"4","key":"86439_CR3","doi-asserted-by":"publisher","first-page":"e2102","DOI":"10.1002\/rmv.2102","volume":"30","author":"JT Blackard","year":"2020","unstructured":"Blackard, J. T., Davies, S. M. & Laskin, B. L. BK Polyomavirus diversity-why viral variation matters. Rev. Med. Virol. 30 (4), e2102 (2020).","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"86439_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/genes13071290","volume":"13","author":"M Borriello","year":"2022","unstructured":"Borriello, M. et al. BK Virus infection and BK-Virus-Associated Nephropathy in Renal Transplant recipients. Genes 13 (7), 1290 (2022).","journal-title":"Genes"},{"issue":"8","key":"86439_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/v14081616","volume":"14","author":"S Kant","year":"2022","unstructured":"Kant, S., Dasgupta, A., Bagnasco, S. & Brennan, D. C. BK Virus Nephropathy in kidney transplantation: a state-of-the-art review. Viruses 14 (8), 1616 (2022).","journal-title":"Viruses"},{"issue":"6","key":"86439_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","volume":"67","author":"I Binet","year":"1999","unstructured":"Binet, I. et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67 (6), 918\u2013922 (1999).","journal-title":"Transplantation"},{"issue":"2","key":"86439_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","volume":"8","author":"P Comoli","year":"2006","unstructured":"Comoli, P., Binggeli, S., Ginevri, F. & Hirsch, H. H. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl. Infect. Dis. 8 (2), 86\u201394 (2006).","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"86439_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.idc.2013.02.002","volume":"27","author":"GP Balba","year":"2013","unstructured":"Balba, G. P., Javaid, B. & Timpone, J. G. BK Polyomavirus infection in the renal transplant recipient. Infect. Dis. Clin. North. Am. 27 (2), 271\u2013283 (2013).","journal-title":"Infect. Dis. Clin. North. Am."},{"issue":"7","key":"86439_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMoa020439","volume":"347","author":"HH Hirsch","year":"2002","unstructured":"Hirsch, H. H. et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl. J. Med. 347 (7), 488\u2013496 (2002).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"86439_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ndt\/15.3.324","volume":"15","author":"V Nickeleit","year":"2000","unstructured":"Nickeleit, V. et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol. Dial Transpl. 15 (3), 324\u2013332 (2000).","journal-title":"Nephrol. Dial Transpl."},{"issue":"11","key":"86439_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/v9110327","volume":"9","author":"F Helle","year":"2017","unstructured":"Helle, F. et al. Biology of the BKPyV: an update. Viruses 9 (11), 327 (2017).","journal-title":"Viruses"},{"issue":"7","key":"86439_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrneph.2012.64","volume":"8","author":"DRJ Kuypers","year":"2012","unstructured":"Kuypers, D. R. J. Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat. Rev. Nephrol. 8 (7), 390\u2013402 (2012).","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"86439_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.str.2016.03.011","volume":"24","author":"CB Buck","year":"2016","unstructured":"Buck, C. B. Exposing the Molecular Machinery of BK Polyomavirus. Structure 24 (4), 495 (2016).","journal-title":"Structure"},{"key":"86439_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.meegid.2014.05.030","volume":"26","author":"B Ehlers","year":"2014","unstructured":"Ehlers, B. & Moens, U. Genome analysis of non-human primate polyomaviruses. Infect. Genet. Evol. 26, 283\u2013294 (2014).","journal-title":"Infect. Genet. Evol."},{"issue":"16","key":"86439_CR15","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ejca.2005.08.019","volume":"41","author":"MK White","year":"2005","unstructured":"White, M. K. & Khalili, K. Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur. J. Cancer. 41 (16), 2537\u20132548 (2005).","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"86439_CR16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1128\/JVI.75.3.1476-1486.2001","volume":"75","author":"M Safak","year":"2001","unstructured":"Safak, M. et al. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 75 (3), 1476\u20131486 (2001).","journal-title":"J. Virol."},{"issue":"1","key":"86439_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2012.06.017","volume":"433","author":"AS Saribas","year":"2012","unstructured":"Saribas, A. S., White, M. K. & Safak, M. JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication. Virology 433 (1), 12\u201326 (2012).","journal-title":"Virology"},{"issue":"5","key":"86439_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/sj.embor.7400406","volume":"6","author":"Y Okada","year":"2005","unstructured":"Okada, Y. et al. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep. 6 (5), 452\u2013457 (2005).","journal-title":"EMBO Rep."},{"issue":"8","key":"86439_CR19","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1128\/JVI.76.8.3828-3838.2002","volume":"76","author":"M Safak","year":"2002","unstructured":"Safak, M., Sadowska, B., Barrucco, R. & Khalili, K. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 76 (8), 3828\u20133838 (2002).","journal-title":"J. Virol."},{"issue":"1","key":"86439_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.virol.2013.05.003","volume":"443","author":"AS Saribas","year":"2013","unstructured":"Saribas, A. S. et al. Essential roles of Leu\/Ile\/Phe-rich domain of JC virus agnoprotein in dimer\/oligomer formation, protein stability and splicing of viral transcripts. Virology 443 (1), 161\u2013176 (2013).","journal-title":"Virology"},{"issue":"3","key":"86439_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1128\/jvi.61.3.937-939.1987","volume":"61","author":"MH Hou-Jong","year":"1987","unstructured":"Hou-Jong, M. H., Larsen, S. H. & Roman, A. Role of the agnoprotein in regulation of simian virus 40 replication and maturation pathways. J. Virol. 61 (3), 937\u2013939 (1987).","journal-title":"J. Virol."},{"key":"86439_CR22","doi-asserted-by":"crossref","unstructured":"Ellis, L. C., Norton, E., Dang, X. & Koralnik, I. J. Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. Fujinami RS, ed. PLOS One. ;8(11):e80840. (2013).","DOI":"10.1371\/journal.pone.0080840"},{"issue":"2","key":"86439_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/jvi.48.2.405-409.1983","volume":"48","author":"RF Margolskee","year":"1983","unstructured":"Margolskee, R. F. & Nathans, D. Suppression of a VP1 mutant of simian virus 40 by missense mutations in serine codons of the viral agnogene. J. Virol. 48 (2), 405\u2013409 (1983).","journal-title":"J. Virol."},{"issue":"3","key":"86439_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/jvi.60.3.1055-1061.1986","volume":"60","author":"S Carswell","year":"1986","unstructured":"Carswell, S. & Alwine, J. C. Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J. Virol. 60 (3), 1055\u20131061 (1986).","journal-title":"J. Virol."},{"key":"86439_CR25","doi-asserted-by":"crossref","unstructured":"Suzuki, T. et al. The human polyoma JC virus agnoprotein acts as a viroporin. Imperiale MJ, ed. PLOS Pathog. ;6(3):e1000801. (2010).","DOI":"10.1371\/journal.ppat.1000801"},{"issue":"46","key":"86439_CR26","doi-asserted-by":"publisher","first-page":"18668","DOI":"10.1073\/pnas.1311457110","volume":"110","author":"T Suzuki","year":"2013","unstructured":"Suzuki, T. et al. Viroporin activity of the JC Polyomavirus is regulated by interactions with the adaptor protein complex 3. Proc. Natl. Acad. Sci. U S A. 110 (46), 18668\u201318673 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"86439_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1743-422X-8-255","volume":"8","author":"IK Sariyer","year":"2011","unstructured":"Sariyer, I. K., Saribas, A. S., White, M. K. & Safak, M. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 8 (1), 255 (2011).","journal-title":"Virol. J."},{"issue":"1","key":"86439_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2009.11.029","volume":"398","author":"MR Myhre","year":"2010","unstructured":"Myhre, M. R., Olsen, G. H., Gosert, R., Hirsch, H. H. & Rinaldo, C. H. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology 398 (1), 12\u201320 (2010).","journal-title":"Virology"},{"issue":"3","key":"86439_CR29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/ijms19030902","volume":"19","author":"MM Panou","year":"2018","unstructured":"Panou, M. M. et al. Agnoprotein is an essential egress factor during BK Polyomavirus infection. Int. J. Mol. Sci. 19 (3), 902 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"86439_CR30","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms20102383","volume":"20","author":"ACL Lee","year":"2019","unstructured":"Lee, A. C. L., Harris, J. L., Khanna, K. K. & Hong, J. H. A Comprehensive Review on current advances in peptide Drug Development and Design. Int. J. Mol. Sci. 20 (10), 2383 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"86439_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1359-6446(04)03104-6","volume":"9","author":"RC Ladner","year":"2004","unstructured":"Ladner, R. C., Sato, A. K., Gorzelany, J. & De Souza, M. Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discovery Today. 9 (12), 525\u2013529 (2004).","journal-title":"Drug Discovery Today"},{"issue":"1","key":"86439_CR32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/molecules16010857","volume":"16","author":"P Molek","year":"2011","unstructured":"Molek, P., Strukelj, B. & Bratkovic, T. Peptide phage display as a Tool for Drug Discovery: Targeting membrane receptors. Molecules 16 (1), 857\u2013887 (2011).","journal-title":"Molecules"},{"issue":"2\u20133","key":"86439_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(00)00068-5","volume":"43","author":"F Nilsson","year":"2000","unstructured":"Nilsson, F., Tarli, L., Viti, F. & Neri, D. The use of phage display for the development of tumour targeting agents. Adv. Drug Delivery Rev. 43 (2\u20133), 165\u2013196 (2000).","journal-title":"Adv. Drug Delivery Rev."},{"issue":"30","key":"86439_CR34","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1016\/j.biomaterials.2010.06.059","volume":"31","author":"MK Yoo","year":"2010","unstructured":"Yoo, M. K. et al. Targeted delivery of chitosan nanoparticles to Peyer\u2019s patch using M cell-homing peptide selected by phage display technique. Biomaterials 31 (30), 7738\u20137747 (2010).","journal-title":"Biomaterials"},{"issue":"22","key":"86439_CR35","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.1158\/0008-5472.CAN-07-2233","volume":"67","author":"TY Lee","year":"2007","unstructured":"Lee, T. Y., Lin, C. T., Kuo, S. Y., Chang, D. K. & Wu, H. C. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery. Cancer Res. 67 (22), 10958\u201310965 (2007).","journal-title":"Cancer Res."},{"issue":"4","key":"86439_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2144\/000112007","volume":"39","author":"Z Li","year":"2005","unstructured":"Li, Z., Zhang, J., Zhao, R., Xu, Y. & Gu, J. Preparation of peptide-targeted phagemid particles using a protein III-modified helper phage. BioTechniques 39 (4), 493\u2013497 (2005).","journal-title":"BioTechniques"},{"issue":"1","key":"86439_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1389201023378490","volume":"3","author":"D Larocca","year":"2002","unstructured":"Larocca, D. et al. Evolving phage vectors for cell targeted gene delivery. Curr. Pharm. Biotechnol. 3 (1), 45\u201357 (2002).","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"10","key":"86439_CR38","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau, J. L. & Dunn, M. K. Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg. Med. Chem. 26 (10), 2700\u20132707 (2018).","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"86439_CR39","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1021\/acschemneuro.3c00248","volume":"14","author":"CE \u00d6z\u00e7elik","year":"2023","unstructured":"\u00d6z\u00e7elik, C. E. et al. Synergistic screening of peptide-based Biotechnological Drug candidates for neurodegenerative diseases using yeast Display and Phage Display. ACS Chem. Neurosci. 14 (19), 3609\u20133621 (2023).","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"86439_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1517\/17460441.2015.1037738","volume":"10","author":"K Omidfar","year":"2015","unstructured":"Omidfar, K. & Daneshpour, M. Advances in phage display technology for drug discovery. Expert Opin. Drug Discovery. 10 (6), 651\u2013669 (2015).","journal-title":"Expert Opin. Drug Discovery"},{"issue":"24","key":"86439_CR41","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.1021\/bi952629y","volume":"35","author":"W Markland","year":"1996","unstructured":"Markland, W., Ley, A. C. & Ladner, R. C. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin. Biochemistry 35 (24), 8058\u20138067 (1996).","journal-title":"Biochemistry"},{"key":"86439_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bios.2016.03.075","volume":"82","author":"P Liu","year":"2016","unstructured":"Liu, P., Han, L., Wang, F., Petrenko, V. A. & Liu, A. Gold nanoprobe functionalized with specific fusion protein selection from phage display and its application in rapid, selective and sensitive colorimetric biosensing of Staphylococcus aureus. Biosens. Bioelectron. 82, 195\u2013203 (2016).","journal-title":"Biosens. Bioelectron."},{"issue":"3","key":"86439_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/1061186X.2016.1258570","volume":"25","author":"L Rahbarnia","year":"2017","unstructured":"Rahbarnia, L. et al. Evolution of phage display technology: from discovery to application. J. Drug Target. 25 (3), 216\u2013224 (2017).","journal-title":"J. Drug Target."},{"issue":"11","key":"86439_CR44","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.3390\/ijms22115513","volume":"22","author":"S Plessers","year":"2021","unstructured":"Plessers, S., Van Deuren, V., Lavigne, R. & Robben, J. High-throughput sequencing of phage display libraries reveals Parasitic Enrichment of Indel mutants caused by amplification Bias. Int. J. Mol. Sci. 22 (11), 5513 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"86439_CR45","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1002\/jcp.27715","volume":"234","author":"AS Saribas","year":"2019","unstructured":"Saribas, A. S., Coric, P., Bouaziz, S. & Safak, M. Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40. J. Cell. Physiol. 234 (6), 8295\u20138315 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"86439_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1128\/jvi.51.2.458-469.1984","volume":"51","author":"RJ Frisque","year":"1984","unstructured":"Frisque, R. J., Bream, G. L. & Cannella, M. T. Human polyomavirus JC virus genome. J. Virol. 51 (2), 458\u2013469 (1984).","journal-title":"J. Virol."},{"issue":"10","key":"86439_CR47","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/jcp.25329","volume":"231","author":"AS Saribas","year":"2016","unstructured":"Saribas, A. S. et al. Emerging from the unknown: structural and functional features of Agnoprotein of Polyomaviruses. J. Cell. Physiol. 231 (10), 2115\u20132127 (2016).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"86439_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/14787210.5.1.105","volume":"5","author":"CH Rinaldo","year":"2007","unstructured":"Rinaldo, C. H. & Hirsch, H. H. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti-Infect Ther. 5 (1), 105\u2013115 (2007).","journal-title":"Expert Rev. Anti-Infect Ther."},{"issue":"1","key":"86439_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/jvi.45.1.428-433.1983","volume":"45","author":"S Nomura","year":"1983","unstructured":"Nomura, S., Khoury, G. & Jay, G. Subcellular localization of the simian virus 40 agnoprotein. J. Virol. 45 (1), 428\u2013433 (1983).","journal-title":"J. Virol."},{"issue":"4705","key":"86439_CR50","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","volume":"228","author":"GP Smith","year":"1985","unstructured":"Smith, G. P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (4705), 1315\u20131317 (1985).","journal-title":"Science"},{"issue":"9","key":"86439_CR51","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/138161210790963788","volume":"16","author":"KC Brown","year":"2010","unstructured":"Brown, K. C. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr. Pharm. Des. 16 (9), 1040\u20131054 (2010).","journal-title":"Curr. Pharm. Des."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86439-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:18:51Z","timestamp":1737461931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86439-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86439-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2718"}}